• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Johnson & Johnson (JNJ)

Common Stock
Sell: $151.38|Buy: $151.59|Change: 0.16 (0.11%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Company profile

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Address

One Johnson and Johnson Plaza
New Brunswick
NJ
USA
08933

Telephone

+1 781 5752718

Website

https://www.jnj.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Johnson & Johnson Annual General Meeting for 20252025-04-25T10:00:00
Johnson & Johnson First Quarter Earnings Conference Call for 20252025-04-16T08:30:00
Johnson & Johnson First Quarter Earnings Results for 20252025-04-16T00:00:00
Johnson & Johnson Annual Report for 20242025-02-14T00:00:00
Johnson & Johnson Fourth Quarter Earnings Conference Call for 20242025-01-23T08:30:00
Johnson & Johnson Fourth Quarter Earnings Results for 20242025-01-23T06:45:00
Johnson & Johnson Third Quarter Earnings Conference Call for 20242024-10-17T08:30:00
Johnson & Johnson Third Quarter Earnings Results for 20242024-10-17T00:00:00
Johnson & Johnson Second Quarter Earnings Result for 20242024-07-17T00:00:00
Johnson & Johnson Second Quarter Earnings Conference Call for 20242024-07-17T00:00:00
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference2024-06-12T14:00:00
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference2024-05-15T11:00:00
Johnson & Johnson BofA Securities Health Care Conference 20242024-05-14T16:40:00
Johnson & Johnson Investor Conference Call2024-05-01T08:00:00

Previous key dates

NameKey Date
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference2024-05-15T11:00:00
Johnson & Johnson BofA Securities Health Care Conference 20242024-05-14T16:40:00
Johnson & Johnson Investor Conference Call2024-05-01T08:00:00
Johnson & Johnson Annual General Meeting for 20242024-04-25T10:00:00
Johnson & Johnson First Quarter Earnings Conference Call for 20242024-04-16T08:30:00
Johnson & Johnson First Quarter Earnings Result for 20242024-04-16T00:00:00
26th Annual Global Healthcare Conference2024-03-13T10:45:00
Leerink Global Biopharma Conferenc2024-03-12T13:00:00
Raymond James 45th Annual Institutional Investors Conference2024-03-05T14:15:00
Johnson & Johnson Annual Report for 20232024-02-16T00:00:00
Johnson & Johnson Fourth Quarter Earnings Conference Call for 20232024-01-23T08:30:00
Johnson & Johnson Fourth Quarter Earnings Results for 20232024-01-23T06:45:00
Johnson & Johnson Third Quarter Earnings Conference Call for 20232023-10-17T08:30:00
Johnson & Johnson Third Quarter Earnings Result for 20232023-10-17T00:00:00
Johnson & Johnson Second Quarter Earnings Conference Call for 20232023-07-20T08:30:00
Johnson & Johnson Second Quarter Earnings Result for 20232023-07-20T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.